MARKETS / NYSE / FMC

NYSE · CHEMICALS & ALLIED PRODUCTS · LARGE CAP

FMC Corp. FMC

19 fiscal years on record · USD · FY2025 reported · SEC filings only

Revenue

$3.5B

▼ 18.3% YoY

Net income

$-2.2B

▼ 756.4% YoY

Free cash flow

$-102.5M

▼ 115.3% YoY

In brief

What this company does

FMC Corporation develops, markets and sells all three major classes of crop protection chemicals (insecticides, herbicides and fungicides), as well as biologicals, crop nutrition and seed treatment products, which it groups as plant health. The company employs approximately 5,500 people, split across its major geographical regions with 21 percent in North America, 13 percent in Latin America, 27 percent in Europe, Middle East and Africa, and 39 percent in Asia as of December 31, 2025. As of December 31, 2025, the company owned approximately 162 active granted U.S. patents and 2,133 active granted foreign patents, and had approximately 1,648 patent applications pending globally. It operates in a single distinct business segment.

Written from the business description in FMC CORPORATION's annual report to the U.S. Securities and Exchange Commission, filed 27 February 2026. Every sentence was checked against that document before publication.

Growth

USD 3.5B

Revenue, FY2025 · full 19-year series below

Revenue $B Net income $B

FY2025 · Revenue 3.5 · Net income -2.2

Compound annual growth

Revenue

−15.8%

−5.7%

+3.4%

+0.7%

Dividend / share

−5.7%

+0.2%

+10.7%

+14.1%

Returned to shareholders

−6.7%

+2.8%

+12.9%

+4.4%

3 yrs

5 yrs

10 yrs

15 yrs

Revenue compounded at −5.7% a year over five years.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability

−65 cents

lost on every revenue dollar

Operating margin Net margin

FY2025 · Operating -47.0% · Net -64.5%

ROE

FY2025 · ROE -68.3%

Gross margin37.0%

Operating margin-47.0%

Net margin-64.5%

Return on assets-21.0%

EBITDAUSD -1.5B

Each USD of equity lost 68 cents this year.

Cash & shareholders

USD 291.3M

returned in FY2025 · dividends + net buybacks

Free cash flow $M

FY2025 · FCF -102.5

Net buybacks $M Dividends $M

FY2025 · Dividends 291.3 · Net buybacks -0.2

Dividends paidUSD 291.3M

Net buybacksUSD -200,000.00

Share of profit-13.0%

Consecutive raises—

USD 291.3M in dividends went back to shareholders in a year without profit.

Total assetsUSD 9.7B

EquityUSD 2.1B

CashUSD 584.5M

Gross debtUSD 3.4B

Net debtUSD 2.8B

Current ratio1.32×

Net debt stands at 134% of equity.

The 19-year record

19 fiscal years

Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative

Metric	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007
Revenue $B	3.5	4.2	4.5	5.8	5.0	4.6	4.6	4.3	2.5	2.5	2.5	3.3	3.1	3.4	3.0	3.1	2.8	3.1	2.6
Operating income $B	−1.6	0.5	0.6	1.1	1.0	0.9	0.8	0.7	0.2	0.3	−0.1	0.4	0.5	0.6	0.6	0.4	0.3	0.5	0.2
EBITDA $B	−1.5	0.7	0.7	1.3	1.2	1.1	1.0	0.9	0.3	0.4	−0.1	0.5	0.6	0.8	0.7	0.5	0.5	0.6	0.4
Income tax $B	0.3	−0.2	−1.1	0.1	0.1	0.2	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0
Net income $B	−2.2	0.3	1.3	0.7	0.7	0.6	0.5	0.5	0.5	0.2	0.5	0.3	0.3	0.4	0.4	0.2	0.2	0.3	0.1
Free cash flow $B	−0.1	0.7	−0.4	0.5	0.8	0.7	0.5	0.3	0.2	0.3	−0.5	0.1	0.1	0.2	0.3	0.3	0.2	0.2	0.2
EPS, diluted $	−17.88	2.72	10.53	5.81	5.73	4.23	3.62	3.69	3.99	1.56	3.66	2.29	2.16	3.00	2.55	1.18	3.12	4.02	1.71
Dividend / sh $	1.82	2.32	2.32	2.17	1.96	1.80	1.64	0.90	0.66	0.66	0.66	0.60	0.54	0.41	0.30	0.25	0.50	0.48	0.41
Payout %	−13	85	22	36	33	41	44	18	17	42	18	25	25	11	11	21	16	11	22
ROE %	−68.3	7.7	33.9	22.7	24.3	20.1	16.9	17.3	23.1	10.9	28.8	20.2	19.6	30.6	30.9	15.6	23.1	33.7	·

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Provenance

Company facts, as filed

How we verify · 0 failures in 89 reconciliationsAUDITED

Reconciled in 19 of 19 fiscal years. 4 checks could not be computed.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures

ActivityChemicals & Allied Products

Listed onNYSE

Incorporated inDelaware

Fiscal year endsDecember 31

Data on record since2007